In contrast, and more recently, a third study has observed the fact that targeting carbonic anhydrase IX may have an antitumor activity in lung cancer [29] or improve antitumor activity of mTOR inhibitors [30]. The gene discussed is MTOR; the disease is lung carcinoma.